Difficulties in maintaining potassium homeostasis in patients with heart failure
- PMID: 17007169
- PMCID: PMC6654365
- DOI: 10.1002/clc.4960290904
Difficulties in maintaining potassium homeostasis in patients with heart failure
Abstract
Potassium (K) concentration plays a significant role in cell metabolism and membrane excitability. The imbalance of serum potassium is important because it can lead to life-threatening events. Potassium balance may be lost both through the neurohormonal mechanisms involved in cardiovascular diseases and through the drugs used in the treatment of this illness. Avoiding both hypo- and hyperkalemia is beneficial in several cardiovascular diseases, especially heart failure. Electrolyte abnormalities are frequently seen complications in subjects with heart failure. Malignant ventricular arrhythmias and sudden cardiac death are particularly feared complications in K+ instability.
Similar articles
-
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.Eur J Prev Cardiol. 2014 Mar;21(3):299-309. doi: 10.1177/2047487313510678. Epub 2013 Nov 4. Eur J Prev Cardiol. 2014. PMID: 24191305 Clinical Trial.
-
Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48. doi: 10.2215/CJN.07821109. Epub 2010 Feb 11. Clin J Am Soc Nephrol. 2010. PMID: 20150448 Review.
-
Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.J Card Fail. 2018 May;24(5):313-320. doi: 10.1016/j.cardfail.2018.03.002. Epub 2018 Mar 20. J Card Fail. 2018. PMID: 29572190 Clinical Trial.
-
Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management.Rev Cardiovasc Med. 2016;17 Suppl 1:S9-S21. doi: 10.3909/ricm17S1S0002. Rev Cardiovasc Med. 2016. PMID: 27725623 Review.
-
Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.J Am Heart Assoc. 2017 Jul 19;6(7):e005428. doi: 10.1161/JAHA.116.005428. J Am Heart Assoc. 2017. PMID: 28724651 Free PMC article.
Cited by
-
Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy.Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1675-82. doi: 10.1007/s00259-011-1826-9. Epub 2011 May 7. Eur J Nucl Med Mol Imaging. 2011. PMID: 21553088 Clinical Trial.
-
Controlled bio-inspired self-organised criticality.PLoS One. 2022 Jan 24;17(1):e0260016. doi: 10.1371/journal.pone.0260016. eCollection 2022. PLoS One. 2022. PMID: 35073308 Free PMC article.
References
-
- Macdonald JE, Struthers AD: What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 2004; 43: 155–161 - PubMed
-
- Halperin ML, Kamel KS: Potassium. Lancet 1998; 352: 135–140 - PubMed
-
- Gennari FJ: Hypokalemia. N Engl J Med 1998; 339: 451–458 - PubMed
-
- Schwinger RH, Erdmann E: Heart failure and electrolyte disturbances. Methods Find Exp Clin Pharmacol 1992; 14: 315–325 - PubMed
-
- Bristow MR, Port JD, Kelly RA: Treatment of heart failure: Pharmacological methods. In Heart Disease. A Textbook of Cardiovascular Medicine, 6th ed. (Eds. Braunwald E, Zipes DP, Libby P.), pp. 562–599. Philadelphia: W.B. Saunders, 2001.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical